Patent · US Active

Anti-LG3 antibodies and uses thereof

US8795974B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 8, 2011
Grant dateAug 5, 2014
Priority date
Expiry dateMar 8, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/245
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method for the prediction of the risk and/or the diagnosis of vascular damage such as acute vascular rejection in a subject, based on the determination of anti-LG3 antibodies levels in a sample from the subject, is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.